A detailed history of Athena Investment Management transactions in Abbott Laboratories stock. As of the latest transaction made, Athena Investment Management holds 10,952 shares of ABT stock, worth $1.23 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
10,952
Previous 10,972 0.18%
Holding current value
$1.23 Million
Previous $1.25 Million 8.74%
% of portfolio
0.73%
Previous 0.8%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$100.73 - $112.44 $2,014 - $2,248
-20 Reduced 0.18%
10,952 $1.14 Million
Q1 2024

May 09, 2024

SELL
$109.52 - $120.96 $657 - $725
-6 Reduced 0.05%
10,972 $1.25 Million
Q2 2023

Jul 31, 2023

SELL
$100.78 - $112.29 $2,015 - $2,245
-20 Reduced 0.18%
10,978 $1.2 Million
Q1 2023

May 10, 2023

SELL
$96.86 - $114.01 $6,586 - $7,752
-68 Reduced 0.61%
10,998 $1.11 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $1.26 Million - $1.54 Million
11,066 New
11,066 $1.31 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Athena Investment Management Portfolio

Follow Athena Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athena Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Athena Investment Management with notifications on news.